<?xml version="1.0" encoding="UTF-8"?>
<article article-type="research-article" dtd-version="1.3" xml:lang="en">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>Czech and Slovak Ophthalmology</journal-title>
      </journal-title-group>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">372</article-id>
      <article-id pub-id-type="doi">10.31348/2025/26</article-id>
      <article-categories>
        <subj-group>
          <subject>Review</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Use of Imaging Modalities in Vogt-Koyanagi-Harada Disease: An Overview</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Karti</surname>
            <given-names>Omer</given-names>
          </name>
          <contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5085-0079</contrib-id>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ayhan</surname>
            <given-names>Ziya</given-names>
          </name>
          <contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4385-2196</contrib-id>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Saatci</surname>
            <given-names>Ali Osman</given-names>
          </name>
          <contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6848-7239</contrib-id>
        </contrib>
      </contrib-group>
      <pub-date date-type="pub" publication-format="electronic">
        <day>7</day>
        <month>7</month>
        <year>2025</year>
      </pub-date>
      <issue>5</issue>
      <elocation-id>1</elocation-id>
      <abstract>
        <p>Aims: Vogt-Koyanagi-Harada (VKH) disease is an autoimmune disorder affecting multiple systems and characterized by bilateral granulomatous uveitis, frequently together with neurological, auditory, and integumentary manifestations. Prompt diagnosis and intervention are a must to prevent irreversible vision loss and possible systemic complications. Fundus imaging plays a pivotal role in the management of VKH, not only to reach the diagnosis but also to monitor disease activity and response to treatment. Fundus photography, fundus autofluorescence imaging, fluorescein angiography, indocyanine green angiography, and optical coherence tomography (OCT) are among the imaging modalities. These methods provide invaluable insights into the different phases of the disease. In addition, OCT angiography enables clinicians to visualize associated retinal and choroidal microvascular changes. Continuous advances in imaging technology assist ophthalmologists to comprehend the VKH pathophysiology and to facilitate its differential diagnosis. Thus, clinical outcomes are improving with timely interventions and personalized treatment approaches. This mini-review provides an overview of VKH disease, with a particular focus on the fundus imaging techniques utilized in its management.</p>
      </abstract>
      <kwd-group>
        <kwd>fluorescein angiography</kwd>
        <kwd>indocyanine green angiography</kwd>
        <kwd>melanocyte-associated antigens</kwd>
        <kwd>optical coherence tomography</kwd>
        <kwd>optical coherence tomography angiography</kwd>
        <kwd>panuveitis</kwd>
        <kwd>Vogt-Koyanagi-Harada disease</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="R1465">
        <mixed-citation>Tugal-Tutkun I, Smit DP, Abu El-Asrar AM, Herbort CP Jr, Thorne JE. Vogt-Koyanagi-Harada Disease. Ocul Immunol Inflamm. 2024 May;32(4):363-366. Epub 2024 Apr 24. doi: 10.1080/09273948.2024.2331401<pub-id pub-id-type="doi">10.1080/09273948.2024.2331401</pub-id></mixed-citation>
      </ref>
      <ref id="R1466">
        <mixed-citation>Tayal A, Daigavane S, Gupta N. Vogt-Koyanagi-Harada Disease: A Narrative Review. Cureus. 2024 Apr 23;16(4):e58867. doi: 10.7759/cureus.58867<pub-id pub-id-type="doi">10.7759/cureus.58867</pub-id></mixed-citation>
      </ref>
      <ref id="R1467">
        <mixed-citation>O’Keefe GA, Rao NA. Vogt-Koyanagi-Harada disease. Surv Ophthalmol. 2017 Jan-Feb;62(1):1-25. Epub 2016 May 27. doi: 10.1016/j. survophthal.2016.05.002<pub-id pub-id-type="doi">10.1016/j</pub-id></mixed-citation>
      </ref>
      <ref id="R1468">
        <mixed-citation>Parlak M, Kocaoglu G, Saatci AO. Vogt-Koyanagi-Harada-Syndrom : Ein ungewöhnlicher Fall mit lacksprungähnlichen Netzhautbefunden [Vogt-Koyanagi-Harada Syndrome : An unusual case with lacquer crack-like retinal findings]. Ophthalmo­ loge. 2017 Dec;114(12):1158-1161. German. doi: 10.1007/s00347- 016-0427-1<pub-id pub-id-type="doi">10.1007/s00347-</pub-id></mixed-citation>
      </ref>
      <ref id="R1469">
        <mixed-citation>Ipek SC, Uslu S, Can G, Ozbagcivan O, Ozdal PC, Saatci AO. An Unusual Presentation of Vogt-Koyanagi-Harada. J Ophthalmic Vis Res. 2021 Jan 20;16(1):140-144. doi: 10.18502/jovr.v16i1.8263<pub-id pub-id-type="doi">10.18502/jovr.v16i1.8263</pub-id></mixed-citation>
      </ref>
      <ref id="R1470">
        <mixed-citation>Urzua CA, Herbort C Jr, Valenzuela RA, Abu El-Asrar AM, Arellanes-Garcia L, Schlaen A, Yamamoto J, Pavesio C. Initial-onset acute and chronic recurrent stages are two distinctive courses of Vogt-Koyanagi-Harada disease. J Ophthalmic Inflamm Infect. 2020 Sep 14;10(1):23. doi: 10.1186/s12348-020-00214-2<pub-id pub-id-type="doi">10.1186/s12348-020-00214-2</pub-id></mixed-citation>
      </ref>
      <ref id="R1471">
        <mixed-citation>Herbort CP Jr, Tugal-Tutkun I, Abu-El-Asrar A, Gupta A, Takeuchi M, Fardeau C, Hedayatfar A, Urzua C, Papasavvas I. Precise, simplified diagnostic criteria and optimised management of initial-onset Vogt-Koyanagi-Harada disease: an updated review. Eye (Lond). 2022 Jan;36(1):29-43. Epub 2021 Jun 18. doi: 10.1038/s41433-021- 01573-3<pub-id pub-id-type="doi">10.1038/s41433-021-</pub-id></mixed-citation>
      </ref>
      <ref id="R1472">
        <mixed-citation>Morita C, Sakata VM, Rodriguez EE, et al. Fundus autofluorescence as a marker of disease severity in Vogt-Koyanagi-Harada disease. Acta Ophthalmol. 2016 Dec;94(8):e820-e821. Epub 2016 Jul 2. doi: 10.1111/aos.13147<pub-id pub-id-type="doi">10.1111/aos.13147</pub-id></mixed-citation>
      </ref>
      <ref id="R1473">
        <mixed-citation>Vasconcelos-Santos DV, Sohn EH, Sadda S, Rao NA. Retinal pigment epithelial changes in chronic Vogt-Koyanagi-Harada disease: fundus autofluorescence and spectral domain-optical coherence tomography findings. Retina. 2010 Jan;30(1):33-41. doi: 10.1097/ IAE.0b013e3181c5970d</mixed-citation>
      </ref>
      <ref id="R1474">
        <mixed-citation>Lavezzo MM, Sakata VM, Morita C, et al. Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes. Orphanet J Rare Dis. 2016 Mar 24;11:29. doi: 10.1186/s13023-016-0412-4<pub-id pub-id-type="doi">10.1186/s13023-016-0412-4</pub-id></mixed-citation>
      </ref>
      <ref id="R1475">
        <mixed-citation>Koizumi H, Maruyama K, Kinoshita S. Blue light and near-infrared fundus autofluorescence in acute Vogt-Koyanagi-Harada disease. Br J Ophthalmol. 2010 Nov;94(11):1499-1505. Epub 2009 Dec 3. doi: 10.1136/bjo.2009.1646651<pub-id pub-id-type="doi">10.1136/bjo.2009.1646651</pub-id></mixed-citation>
      </ref>
      <ref id="R1476">
        <mixed-citation>Ayata A, Dogru S, Senol MG, Unal M, Ersanli D, Bilge AH. Autofluorescence findings in Vogt-Koyanagi-Harada disease. Eur J Ophthalmol. 2009 Nov-Dec;19(6):1094-1097. doi: 10.1177/112067210901900636<pub-id pub-id-type="doi">10.1177/112067210901900636</pub-id></mixed-citation>
      </ref>
      <ref id="R1477">
        <mixed-citation>Heussen FM, Vasconcelos-Santos DV, Pappuru RR, Walsh AC, Rao NA, Sadda SR. Ultra-wide-field green-light (532-nm) autofluorescence imaging in chronic Vogt-Koyanagi-Harada disease. Ophthalmic Surg Lasers Imaging. 2011 Jul-Aug;42(4):272-277. Epub 2011 May 12. doi: 10.3928/15428877-20110505-01.<pub-id pub-id-type="doi">10.3928/15428877-20110505-01</pub-id></mixed-citation>
      </ref>
      <ref id="R1478">
        <mixed-citation>Meleth AD, Sen HN. Use of fundus autofluorescence in the diagnosis and management of uveitis. Int Ophthalmol Clin. 2012 Fall;52(4):45-54. doi: 10.1097/IIO.0b013e3182662ee9<pub-id pub-id-type="doi">10.1097/IIO.0b013e3182662ee9</pub-id></mixed-citation>
      </ref>
      <ref id="R1479">
        <mixed-citation>Arellanes-García L, Hernández-Barrios M, Fromow-Guerra J, Cervantes-Fanning P. Fluorescein fundus angiographic findings in Vogt-Koyanagi-Harada syndrome. Int Ophthalmol. 2007 Apr- Jun;27(2-3):155-161. Epub 2007 Jan 26. doi: 10.1007/s10792-006- 9027-4<pub-id pub-id-type="doi">10.1007/s10792-006-</pub-id></mixed-citation>
      </ref>
      <ref id="R1480">
        <mixed-citation>Chee SP, Jap A, Cheung CM. The prognostic value of angiography in Vogt-Koyanagi-Harada disease. Am J Ophthalmol. 2010 Dec;150(6):888-893. Epub 2010 Oct 8.doi: 10.1016/j. ajo.2010.06.029<pub-id pub-id-type="doi">10.1016/j</pub-id></mixed-citation>
      </ref>
      <ref id="R1481">
        <mixed-citation>Okada AA, Mizusawa T, Sakai J, Usui M. Videofunduscopy and videoangiography using the scanning laser ophthalmoscope in Vogt-Koyanagi-Harada syndrome. Br J Ophthalmol. 1998 Oct;82(10):1175-81. doi: 10.1136/bjo.82.10.1175<pub-id pub-id-type="doi">10.1136/bjo.82.10.1175</pub-id></mixed-citation>
      </ref>
      <ref id="R1482">
        <mixed-citation>Fardeau C, Tran TH, Gharbi B, Cassoux N, Bodaghi B, LeHoang P. Retinal fluorescein and indocyanine green angiography and optical coherence tomography in successive stages of Vogt-Koyanagi-Harada disease. Int Ophthalmol. 2007 Apr-Jun;27(2-3):163-172. Epub 2007 Feb 2. doi: 10.1007/s10792-006-9024-7<pub-id pub-id-type="doi">10.1007/s10792-006-9024-7</pub-id></mixed-citation>
      </ref>
      <ref id="R1483">
        <mixed-citation>Kim P, Sun HJ, Ham DI. Ultra-wide-field angiography findings in acute Vogt-Koyanagi-Harada disease. Br J Ophthalmol. 2019 Jul;103(7):942-948. Epub 2018 Aug 12. doi: 10.1136/bjophthalmol-2018-312569<pub-id pub-id-type="doi">10.1136/bjophthalmol-2018-312569</pub-id></mixed-citation>
      </ref>
      <ref id="R1484">
        <mixed-citation>Herbort CP, Mantovani A, Bouchenaki N. Indocyanine green angiography in Vogt-Koyanagi-Harada disease: angiographic signs and utility in patient follow-up. Int Ophthalmol. 2007 Apr- Jun;27(2-3):173-182. Epub 2007 Apr 25. doi: 10.1007/s10792-007- 9060-y<pub-id pub-id-type="doi">10.1007/s10792-007-</pub-id></mixed-citation>
      </ref>
      <ref id="R1485">
        <mixed-citation>Altan-Yaycioglu R, Akova YA, Akca S, Yilmaz G. Inflammation of the posterior uvea: findings on fundus fluorescein and indocyanine green angiography. Ocul Immunol Inflamm. 2006 Jun;14(3):171-</mixed-citation>
      </ref>
      <ref id="R1486">
        <mixed-citation>Knecht PB, Mantovani A, Herbort CP. Indocyanine green angiography-guided management of Vogt-Koyanagi-Harada disease: differentiation between choroidal scars and active lesions. Int Ophthalmol. 2013 Oct;33(5):571-577. Epub 2013 Jan 1. doi: 10.1007/ s10792-012-9692-4</mixed-citation>
      </ref>
      <ref id="R1487">
        <mixed-citation>Inomata H, Sakamoto T. Immunohistochemical studies of Vogt-Koyanagi-Harada disease with sunset sky fundus. Curr Eye Res. 1990;9 Suppl:35-40. doi: 10.3109/02713689008999417<pub-id pub-id-type="doi">10.3109/02713689008999417</pub-id></mixed-citation>
      </ref>
      <ref id="R1488">
        <mixed-citation>Miyanaga M, Kawaguchi T, Miyata K, Horie S, Mochizuki M, Herbort CP. Indocyanine green angiography findings in initial acute pretreatment Vogt-Koyanagi-Harada disease in Japanese patients. Jpn J Ophthalmol. 2010 Sep;54(5):377-382. Epub 2010 Nov 5. doi: 10.1007/s10384-010-0853-6<pub-id pub-id-type="doi">10.1007/s10384-010-0853-6</pub-id></mixed-citation>
      </ref>
      <ref id="R1489">
        <mixed-citation>Balci O, Gasc A, Jeannin B, Herbort CP Jr. Enhanced depth imaging is less suited than indocyanine green angiography for close monitoring of primary stromal choroiditis: a pilot report. Int Ophthalmol. 2017 Jun;37(3):737-748. Epub 2016 Aug 2. doi: 10.1007/ s10792-016-0303-7</mixed-citation>
      </ref>
      <ref id="R1490">
        <mixed-citation>Ataş F, Kaya M, Saatci AO. Bacillary Layer Detachment in Acute Vogt-Koyanagi-Harada Disease. Turk J Ophthalmol. 2022 Dec 28;52(6):400-404. doi: 10.4274/tjo.galenos.2021.86821<pub-id pub-id-type="doi">10.4274/tjo.galenos.2021.86821</pub-id></mixed-citation>
      </ref>
      <ref id="R1491">
        <mixed-citation>Atas F, Kaya M, Saatci AO. The effect of pulse steroid treatment of ten days’ long on the improvement of bacillary layer detachment in a patient with Vogt-Koyanagi Harada disease. Rom J Ophthalmol. 2021 Apr-Jun;65(2):183-186. doi: 10.22336/rjo.2021.36<pub-id pub-id-type="doi">10.22336/rjo.2021.36</pub-id></mixed-citation>
      </ref>
      <ref id="R1492">
        <mixed-citation>Ben Aoun S, Ksiaa I, Nefzi D, et al. OCT and OCT-A Findings in Convalescent Inactive Vogt-Koyanagi-Harada Disease. Ocul Immunol Inflamm. 2024 May;32(4):407-414. Epub 2023 Nov 10. doi: 10.1080/09273948.2023.2274962<pub-id pub-id-type="doi">10.1080/09273948.2023.2274962</pub-id></mixed-citation>
      </ref>
      <ref id="R1493">
        <mixed-citation>Fabro F, Herbort CP. Need for Quantitative Measurement Methods for Posterior Uveitis: Comparison of Dual FA/ICGA Angiography, EDI-OCT Choroidal Thickness and SUN Vitreous Haze Evaluation in Stromal Choroiditis. Klin Monbl Augenheilkd. 2018 Apr;235(4):424-</mixed-citation>
      </ref>
      <ref id="R1494">
        <mixed-citation>Tagawa Y, Namba K, Mizuuchi K, et al. Choroidal thickening prior to anterior recurrence in patients with Vogt-Koyanagi-Harada disease. Br J Ophthalmol. 2016 Apr;100(4):473-477. Epub 2015 Aug</mixed-citation>
      </ref>
      <ref id="R1495">
        <mixed-citation>Hirooka K, Saito W, Namba K, et al. Early post-treatment choroidal thickness to alert sunset glow fundus in patients with Vogt-Koyanagi-Harada disease treated with systemic corticosteroids. PLoS One. 2017 Feb 27;12(2):e0172612. doi: 10.1371/journal.pone.0172612<pub-id pub-id-type="doi">10.1371/journal.pone.0172612</pub-id></mixed-citation>
      </ref>
      <ref id="R1496">
        <mixed-citation>da Silva FT, Sakata VM, Nakashima A, et al. Enhanced depth imaging optical coherence tomography in long-standing Vogt-Koyanagi-Harada disease. Br J Ophthalmol. 2013 Jan;97(1):70-74. Epub 2012 Oct 25. doi: 10.1136/bjophthalmol-2012-302089<pub-id pub-id-type="doi">10.1136/bjophthalmol-2012-302089</pub-id></mixed-citation>
      </ref>
      <ref id="R1497">
        <mixed-citation>Nazari H, Hariri A, Hu Z, Ouyang Y, Sadda S, Rao NA. Choroidal atrophy and loss of choriocapillaris in convalescent stage of Vogt-Koyanagi-Harada disease: in vivo documentation. J Ophthalmic Inflamm Infect. 2014 Mar 22;4:9. doi: 10.1186/1869-5760-4-9<pub-id pub-id-type="doi">10.1186/1869-5760-4-9</pub-id></mixed-citation>
      </ref>
      <ref id="R1498">
        <mixed-citation>Takahashi H, Takase H, Ishizuka A, et al. Choroidal thickness in convalescent vogt-koyanagi-harada disease. Retina. 2014 Apr;34(4):775-780. doi: 10.1097/IAE.0b013e3182a6b3f6<pub-id pub-id-type="doi">10.1097/IAE.0b013e3182a6b3f6</pub-id></mixed-citation>
      </ref>
      <ref id="R1499">
        <mixed-citation>Karti O, Saatci AO. Optical Coherence Tomography Angiography in Eyes with Non-infectious Posterior Uveitis; Some Practical Aspects. Med Hypothesis Discov Innov Ophthalmol. 2019 Winter;8(4):312-322. Epub 2019 Oct 1.</mixed-citation>
      </ref>
      <ref id="R1500">
        <mixed-citation>Aggarwal K, Agarwal A, Mahajan S, et al. OCTA Study Group. The Role of Optical Coherence Tomography Angiography in the Diagnosis and Management of Acute Vogt-Koyanagi-Harada Disease. Ocul Immunol Inflamm. 2018;26(1):142-153. Epub 2016 Jul 20 doi: 10.1080/09273948.2016.1195001<pub-id pub-id-type="doi">10.1080/09273948.2016.1195001</pub-id></mixed-citation>
      </ref>
      <ref id="R1501">
        <mixed-citation>Liang R, Geng J, Jiang H, Jin S, Wang X, Liu X. Optical Coherence Tomography Angiography in Vogt-Koyanagi-Harada Patients: A Systematic Review and Meta-Analysis. Curr Eye Res. 2024 Mar 8:1-10. doi: 10.1080/02713683.2024.2327054<pub-id pub-id-type="doi">10.1080/02713683.2024.2327054</pub-id></mixed-citation>
      </ref>
      <ref id="R1502">
        <mixed-citation>Fan S, Lin D, Hu J, et al. Evaluation of microvasculature altera­ tions in convalescent Vogt-Koyanagi-Harada disease using optical coherence tomography angiography. Eye (Lond). 2021 Jul;35(7):1993-1998. Epub 2020 Oct 6. doi: 10.1038/s41433-020- 01210-5<pub-id pub-id-type="doi">10.1038/s41433-020-</pub-id></mixed-citation>
      </ref>
      <ref id="R1503">
        <mixed-citation>Liang A, Jia S, Gao F, et al. Decrease of choriocapillary vascular density measured by optical coherence tomography angiography in Vogt-Koyanagi-Harada disease. Graefes Arch Clin Exp Ophthalmol. 2021 Nov;259(11):3395-3404. Epub 2021 Jul 3. doi: 10.1007/ s00417-021-05238-5</mixed-citation>
      </ref>
      <ref id="R1504">
        <mixed-citation>Ipek SC, Ayhan Z, Emre S, Saatci AO. Favorable clinical outcome with intravitreal aflibercept treatment in a case with bilateral choroidal neovascular membrane and quiescent Vogt-Koyanagi-Harada syndrome. GMS Ophthalmol Cases. 2020 Apr 17;10:Doc23. doi: 10.3205/oc000150<pub-id pub-id-type="doi">10.3205/oc000150</pub-id></mixed-citation>
      </ref>
      <ref id="R1505">
        <mixed-citation>Mekkawy MO, Fouad YA, Nowara M, Aziz IA. Clinical and multimodal imaging characteristics of eyes with Vogt-Koyanagi-Harada disease: An Egyptian experience. Oman J Ophthalmol. 2023 Feb 21;16(1):88-93. doi: 10.4103/ojo.ojo_376_21<pub-id pub-id-type="doi">10.4103/ojo.ojo_376_21</pub-id></mixed-citation>
      </ref>
      <ref id="R1506">
        <mixed-citation>Pichi F, Salas EC, D de Smet M, Gupta V, Zierhut M, Munk MR. Standardisation of optical coherence tomography angiography nomenclature in uveitis: first survey results. Br J Ophthalmol. 2021 Jul;105(7):941-947. Epub 2020 Jul 29. doi: 10.1136/bjophthalmol-2020-316881<pub-id pub-id-type="doi">10.1136/bjophthalmol-2020-316881</pub-id></mixed-citation>
      </ref>
      <ref id="R1507">
        <mixed-citation>Guo S, Xia L, Hu R, Wang J, Yang P. Vascular changes and irreversible complications in 120° fundus using widefield swept-source optical coherence tomography angiography in vogt-koyanagi-harada disease. Retina. 2025 Jan 1;45(1):79-87. doi: 10.1097/ IAE.0000000000004259. PMID: 39173134</mixed-citation>
      </ref>
      <ref id="R1508">
        <mixed-citation>Kinoshita T, Imaizumi H, Miyamoto H, Katome T, Mitamura Y. Detection of choroidal folds in patients with vogt-koyanagi-harada disease by retromode scanning laser ophthalmoscopy. Retin Cases Brief Rep. 2016 Spring;10(2):160-164. doi: 10.1097/ ICB.0000000000000216</mixed-citation>
      </ref>
      <ref id="R1509">
        <mixed-citation>Yasuda S, Yoshida T, Suzuki Y, et al. Retromode Infrared Scanning Laser Ophthalmoscopy in Vogt-Koyanagi-Harada Disease. Graefes Arch Clin Exp Ophthalmol. 2024 Nov 25. Epub ahead of print. doi: 10.1007/s00417-024-06693-6<pub-id pub-id-type="doi">10.1007/s00417-024-06693-6</pub-id></mixed-citation>
      </ref>
      <ref id="R1510">
        <mixed-citation>doi: 10.1080/09273940600660524<pub-id pub-id-type="doi">10.1080/09273940600660524</pub-id></mixed-citation>
      </ref>
      <ref id="R1511">
        <mixed-citation>English. Epub 2018 Apr 18. doi: 10.1055/s-0043-124966<pub-id pub-id-type="doi">10.1055/s-0043-124966</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
